Siga Technologies, Inc.
A pharmaceutical company that makes antiviral drugs for serious infectious diseases and biothreats, best known for TPOXX (tecovirimat), the first drug approved in the U.S. to treat smallpox and stockpiled by governments against bioterror threats. Founded in 1995 by Steven Oliveira and based in New York City, it works with U.S. agencies like BARDA on medical countermeasures. Fun fact: since smallpox was eradicated, TPOXX won approval under the FDA's "Animal Rule," which allows a drug to be approved on animal studies when human trials aren't possible.
Granted 59.9K
Granted 105.4K
Granted 76.0K
Granted 256.1K
Granted 22.8K · Sold 30.0K
Granted 105.4K
Granted 105.4K
Granted 105.4K
Granted 22.8K
Granted 105.4K
Granted 67.9K
Granted 92.0K
Granted 22.8K
Granted 24.1K
Granted 24.7K
Granted 24.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Luckshire Daniel JExecutive VP & CFO · 6 transactions | +5.7% | 280.5K | 59.9K | — | — |
| Marshall Joseph W IIIDirector · 10 transactions | +42.7% | 246.5K | 105.4K | — | — |
| Hruby Dennis EEVP & Chief Scientific Officer · 6 transactions | +37.3% | 202.5K | 76.0K | — | — |
| Nguyen DiemChief Executive Officer, Director · 8 transactions | — | 185.8K | 256.1K | — | — |
| Antal JamesDirector · 3 transactions | -10.7% | 116.9Kas of Jun 2022 | 22.8K | — | 30.0K |
| Durnan Jaymie ADirector · 10 transactions | +491.7% | 88.8K | 105.4K | — | — |
| Nemirovsky JulianDirector · 10 transactions | — | 81.0K | 105.4K | — | — |
| Phillips Holly L.Director · 10 transactions | — | 81.0K | 105.4K | — | — |
| Plansky Michael C.Director · 2 transactions | +26.6% | 76.0Kas of Jun 2022 | 22.8K | — | — |
| Nabel Gary J.Director · 10 transactions | — | 73.8K | 105.4K | — | — |
| Ford Harold Eugene Jr.Director · 6 transactions | — | 54.8K | 67.9K | — | — |
| Miller Larry R.General Counsel · 10 transactions | — | 51.9K | 92.0K | — | — |
| Kane JulieDirector · 2 transactions | +49.2% | 48.5Kas of Jun 2022 | 22.8K | — | — |
| Keane John MDirector · 2 transactions | — | 24.1K | 24.1K | — | — |
| Knisely Evan A.Director · 2 transactions | — | 17.3Kas of Jun 2024 | 24.7K | — | — |
| Varma JayEVP & Chief Medical Officer, Director · 2 transactions | — | 17.3Kas of Jun 2024 | 24.7K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 5 years: -30.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.